Senior Global Medical Director Oncology

Senior Global Medical Director, Oncology

We are seeking a senior, strategic medical leader to own the global medical strategy for a lung cancer asset. You will design and deliver medical strategies, evidence generation and scientific engagement across the product lifecycle. As the lead of a cross-functional global medical team, you will work closely with R&D, commercial, regional medical teams and external partners to translate scientific insight into practical impact for patients. We value clear thinking, collaboration and measurable outcomes. This role offers growth, visible influence on global medical strategy, and the chance to contribute to GSK’s mission of uniting science, technology and talent to get ahead of disease together.

Key responsibilities

• Lead development and implementation of the global medical strategy for a lung cancer asset and integrated evidence strategies.

• Chair or co‑lead a cross‑functional global medical team to align medical strategy with market needs.

• Establish and manage trusted partnerships with academic centres, research networks, clinical experts, patient groups and payers to gather insights and shape strategy.

• Translate external and internal insights into evidence generation plans that inform development, access and medical strategy

• Partner with research & development to provide medical input into the asset strategy and clinical development plans 

• Represent GSK externally at scientific meetings and internally as the medical lead for the asset.

• Ensure scientific quality, governance and compliance for global medical materials and external interactions.

• Provide line management, mentoring and performance management for Global Medical Directors

Why You?

We are seeking people who bring scientific credibility, strategic leadership and a collaborative mindset. You will join a global team and have a direct line of influence on evidence generation and medical strategy for oncology. The role can be based in the UK, Switzerland or the US. Travel will be required to attend scientific meetings, meet external partners and colleagues.

Essential qualifications & experience

• Advanced degree in medicine, pharmacy, life sciences or related field (MD, PharmD, PhD or equivalent).

• Significant experience (typically 10+ years) in oncology medical affairs, clinical development or related roles within pharma/biotech.

• Proven experience designing and delivering global medical and evidence generation strategies 

• Strong track record of scientific engagement with healthcare professionals and academic partners.

• Experience working in cross-functional, matrixed and global teams.

• Experience in mentoring or leading small teams and developing talent.

• Excellent English communication skills with the ability to make complex science clear.

Preferred Qualification
If you have the following characteristics, it would be a plus:
- Deep disease knowledge in lung cancer.

- Experience in late-stage clinical development, phase IIIb/IV studies or real-world evidence programmes.
- Experience managing global congress strategy and scientific communications.
- Experience negotiating and managing external partnerships, budgets and vendors.

- Knowledge of regulatory, legal and compliance considerations across key markets.

Ready to apply?
If this role feels like the next step for you, we want to hear from you. Please submit your CV and a short cover letter describing a recent medical strategy, partnership or programme you led and the outcomes achieved. We welcome applicants who bring curiosity, collaboration and a commitment to inclusion. Join us and help get ahead of disease together.

Please visit  GSK US Benefits Summary to learn more about the comprehensive benefits program GSK offers US employees.

Why GSK?

Uniting science, technology and talent to get ahead of disease together.

GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medici